MedPath

Fluorescent Approach for Refined Endoscopic Marking With Clip Localization and Identification Procedure

Phase 2
Recruiting
Conditions
Colon Cancer
Registration Number
NCT06714292
Lead Sponsor
Seoul National University Hospital
Brief Summary

* Title of the Study Testing a Fluorescent Surgical Marker Clip for Tumor Localization in Minimally Invasive Colorectal Surgery

* Purpose of the Study This study aims to determine if a fluorescent surgical marker clip can accurately and safely localize tumor locations in the colon during minimally invasive colorectal surgery. The study will compare the effectiveness of this clip to the current method using a dye called Indocyanine Green (ICG).

The main questions the investigators aim to address are:

Can the clip safely and effectively localize tumor sites compared to ICG dye? What side effects or medical issues might arise with the use of the clip?

-Study Design Assignment

Participants will be randomly assigned to one of two groups:

The clip group: A fluorescent clip will be placed near the tumor. The dye group: ICG dye will be injected near the tumor.

Procedures Participants will undergo a colonoscopy to mark the tumor location before surgery using either the fluorescent clip or ICG dye.

* Follow-Up Participants will attend follow-up visits after surgery to monitor for any side effects or complications.

* Eligibility Inclusion Criteria

Participants may qualify if:

They are 19 years or older. They are scheduled for minimally invasive colorectal surgery for a tumor or suspected tumor.

Exclusion Criteria

Participants cannot enroll if:

They have certain medical conditions, such as blood clotting disorders or allergies to metals or iodine.

They are pregnant or breastfeeding.

-Participant Role By participating, individuals will contribute to advancing research aimed at improving methods for tumor localization during surgery, potentially leading to enhanced surgical outcomes in the future.

For questions or concerns, participants are encouraged to contact the investigators or the research team.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
110
Inclusion Criteria
  • Aged 19years or more
  • With colonic neoplasm planning minimally invasive surgery
  • Need localization of lesion before surgery
Exclusion Criteria
  • Planned total proctocolectomy
  • Contraindication of colonoscopy
  • On pregnancy or breast-feeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Success rate of localizationIn operation

Accuracy of Identifying the Exact Tumor Location

Experimental Group: Considered successful when the tumor can be observed through the applied clips using fluorescence imaging.

Control Group: Considered successful when the ICG-tattooed tumor can be observed.

Secondary Outcome Measures
NameTimeMethod
Reconfirmation Rate via Intraoperative Colonoscopy (%)In operation

The proportion of cases where intraoperative colonoscopy was performed.

Total Operation Time (minutes)From start of operation to end of operation.

The time from skin incision to skin closure.

Time Required for Endoscopic Marking Procedure (minutes)From identifying of tumor in colonoscopy to completing the clipping or injection of ICG

The time from identifying the tumor to completing the attachment of all required clips for marking the tumor or completing the injection of ICG.

Longitudinal Length of ICG Spread in the Control Group (mm)After resection of colon, in operation

In ICG group, measure the length of tattooed area using a disposable paper ruler on the serosa side of colon.

Trial Locations

Locations (3)

National Cancer Center

🇰🇷

Goyang, Gyeonggi-do, Korea, Republic of

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul Boramae Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath